MIGLITOL

Miglitol Adverse Events Reported to the FDA Over Time

How are Miglitol adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Miglitol, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Miglitol is flagged as the suspect drug causing the adverse event.

Most Common Miglitol Adverse Events Reported to the FDA

What are the most common Miglitol adverse events reported to the FDA?

Hepatic Function Abnormal	110 (7.01%)
Liver Disorder	86 (5.48%)
Alanine Aminotransferase Increased	82 (5.22%)
Aspartate Aminotransferase Increase...	78 (4.97%)
Hypoglycaemia	67 (4.27%)
Gamma-glutamyltransferase Increased	47 (2.99%)
Abdominal Pain	34 (2.17%)
Blood Alkaline Phosphatase Increase...	33 (2.1%)
Diarrhoea	32 (2.04%)
Abdominal Distension	30 (1.91%)
Ileus	29 (1.85%)
	Show More
Nausea	27 (1.72%)
Intestinal Obstruction	25 (1.59%)
Liver Function Test Abnormal	25 (1.59%)
Pneumatosis Intestinalis	21 (1.34%)
Anorexia	20 (1.27%)
Loss Of Consciousness	19 (1.21%)
Malaise	19 (1.21%)
Hepatic Enzyme Increased	17 (1.08%)
Jaundice	15 (.96%)
Vomiting	14 (.89%)
Blood Bilirubin Increased	13 (.83%)
Blood Lactate Dehydrogenase Increas...	12 (.76%)
Blood Creatine Phosphokinase Increa...	11 (.7%)
Flatulence	10 (.64%)
Gastric Ulcer	10 (.64%)
Large Intestine Carcinoma	10 (.64%)
Thrombocytopenia	10 (.64%)
Anaemia	9 (.57%)
Intestinal Ischaemia	9 (.57%)
Transaminases Increased	9 (.57%)
Abdominal Pain Upper	8 (.51%)
Asthenia	8 (.51%)
Ileus Paralytic	8 (.51%)
In-stent Coronary Artery Restenosis	8 (.51%)
Melaena	8 (.51%)
Rhabdomyolysis	8 (.51%)
Blood Glucose Increased	7 (.45%)
Drug Exposure During Pregnancy	7 (.45%)
Hepatocellular Injury	7 (.45%)
Back Pain	6 (.38%)
Blood Potassium Abnormal	6 (.38%)
Blood Pressure Increased	6 (.38%)
Dehydration	6 (.38%)
Dermatitis Exfoliative	6 (.38%)
Diverticulum Intestinal Haemorrhagi...	6 (.38%)
Hepatitis	6 (.38%)
Ketosis	6 (.38%)
Prostate Cancer	6 (.38%)
Pruritus	6 (.38%)
Subileus	6 (.38%)
Ventricular Extrasystoles	6 (.38%)
Acute Myocardial Infarction	5 (.32%)
Altered State Of Consciousness	5 (.32%)
Blood Creatinine Increased	5 (.32%)
Constipation	5 (.32%)
Diabetes Mellitus Inadequate Contro...	5 (.32%)
Fall	5 (.32%)
Hemiplegia	5 (.32%)
Hyperglycaemia	5 (.32%)
Hyperkalaemia	5 (.32%)
Hypertension	5 (.32%)
Insomnia	5 (.32%)
Pruritus Generalised	5 (.32%)
Syncope	5 (.32%)
Abortion	4 (.25%)
Acidosis	4 (.25%)
Blood Potassium Increased	4 (.25%)
Convulsion	4 (.25%)
Coronary Artery Restenosis	4 (.25%)
Decreased Appetite	4 (.25%)
Drug Interaction	4 (.25%)
Epistaxis	4 (.25%)
Erythema Multiforme	4 (.25%)
Gastric Cancer	4 (.25%)
Hypoproteinaemia	4 (.25%)
Influenza	4 (.25%)
Oedema	4 (.25%)
Oral Herpes	4 (.25%)
Pneumonia	4 (.25%)
Pyrexia	4 (.25%)
Thyroid Cancer	4 (.25%)
Tremor	4 (.25%)
Cerebral Infarction	3 (.19%)
Chest Discomfort	3 (.19%)
Chromaturia	3 (.19%)
Colonic Polyp	3 (.19%)
Disseminated Intravascular Coagulat...	3 (.19%)
Dizziness	3 (.19%)
Dysarthria	3 (.19%)
Dyslalia	3 (.19%)
Electrolyte Imbalance	3 (.19%)
Extrasystoles	3 (.19%)
Feeling Abnormal	3 (.19%)
Gastrointestinal Haemorrhage	3 (.19%)
Glycosylated Haemoglobin Increased	3 (.19%)
Haematochezia	3 (.19%)
Hypersensitivity	3 (.19%)
Hypoaesthesia Facial	3 (.19%)
Hyporeflexia	3 (.19%)
Intentional Overdose	3 (.19%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Miglitol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Miglitol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Miglitol

What are the most common Miglitol adverse events reported to the FDA?

Hepatobiliary	271 (17.26%)
Hepatic And Hepatobiliary	229 (14.59%)
Gastrointestinal Signs	152 (9.68%)
Glucose Metabolism Disorders	79 (5.03%)
Gastrointestinal Stenosis And Obstr...	64 (4.08%)
Enzyme	56 (3.57%)
Neurological	49 (3.12%)
Gastrointestinal Motility And Defec...	47 (2.99%)
Epidermal And Dermal Conditions	35 (2.23%)
Appetite And General Nutritional	26 (1.66%)
Gastrointestinal Hemorrhages	17 (1.08%)
	Show More
Gastrointestinal Neoplasms Malignan...	17 (1.08%)
Cardiac And Vascular Investigations	15 (.96%)
Electrolyte And Fluid Balance Condi...	15 (.96%)
Gastrointestinal Ulceration And Per...	15 (.96%)
Procedural And Device Related Injur...	15 (.96%)
Urinary Tract Signs	15 (.96%)
Acid-base	14 (.89%)
Anemias Nonhemolytic And Marrow Dep...	14 (.89%)
Infections - Pathogen Unspecified	14 (.89%)
Renal And Urinary Tract Investigati...	14 (.89%)
Movement Disorders	13 (.83%)
Metabolic, Nutritional And Blood Ga...	12 (.76%)
Muscle	12 (.76%)
Cardiac Arrhythmias	11 (.7%)
Coronary Artery	11 (.7%)
Viral Infectious	11 (.7%)
Injuries	10 (.64%)
Platelet	10 (.64%)
Water, Electrolyte And Mineral	10 (.64%)
Gastrointestinal Vascular Condition...	9 (.57%)
Renal Disorders	9 (.57%)
Abortions And Stillbirth	8 (.51%)
Central Nervous System Vascular	8 (.51%)
Chemical Injury And Poisoning	8 (.51%)
Diverticular	8 (.51%)
Hematology Investigations	7 (.45%)
Musculoskeletal And Connective Tiss...	7 (.45%)
White Blood Cell	7 (.45%)
Reproductive Neoplasms Male Maligna...	6 (.38%)
Seizures	6 (.38%)
Sleep Disorders	6 (.38%)
Upper Respiratory Tract Disorders	6 (.38%)
Anxiety Disorders	5 (.32%)
Protein And Amino Acid Metabolism	5 (.32%)
Vascular Hypertensive	5 (.32%)
Body Temperature Conditions	4 (.25%)
Coagulopathies And Bleeding Diathes...	4 (.25%)
Endocrine Neoplasms Malignant And U...	4 (.25%)
Gastrointestinal Inflammatory Condi...	4 (.25%)
Nephropathies	4 (.25%)
Oral Soft Tissue Conditions	4 (.25%)
Peritoneal And Retroperitoneal Cond...	4 (.25%)
Physical Examination Topics	4 (.25%)
Skin Appendage Conditions	4 (.25%)
Therapeutic And Nontherapeutic Effe...	4 (.25%)
Allergic Conditions	3 (.19%)
Benign Neoplasms Gastrointestinal	3 (.19%)
Exocrine Pancreas Conditions	3 (.19%)
Fatal Outcomes	3 (.19%)
Immunology And Allergy	3 (.19%)
Medication Errors	3 (.19%)
Suicidal And Self-injurious Behavio...	3 (.19%)
Vascular	3 (.19%)
Abdominal Hernias And Other Abdomin...	2 (.13%)
Angiedema And Urticaria	2 (.13%)
Bone And Joint Injuries	2 (.13%)
Bone Disorders	2 (.13%)
Cardiac Disorder Signs	2 (.13%)
Decreased And Nonspecific Blood Pre...	2 (.13%)
Gallbladder	2 (.13%)
Heart Failures	2 (.13%)
Hepatobiliary Neoplasms Malignant A...	2 (.13%)
Inner Ear And Viiith Cranial Nerve	2 (.13%)
Leukemias	2 (.13%)
Lifestyle Issues	2 (.13%)
Lymphomas	2 (.13%)
Lymphomas Non-hodgkins T-cell	2 (.13%)
Musculoskeletal And Connective Tiss...	2 (.13%)
Musculoskeletal And Soft Tissue Inv...	2 (.13%)
Neuromuscular	2 (.13%)
Ocular Infections, Irritations And ...	2 (.13%)
Ocular Neuromuscular	2 (.13%)
Protein And Chemistry Analyses	2 (.13%)
Respiratory	2 (.13%)
Spleen, Lymphatic And Reticulendoth...	2 (.13%)
Administration Site Reactions	1 (.06%)
Anal And Rectal Conditions	1 (.06%)
Bladder And Bladder Neck Disorders	1 (.06%)
Changes In Physical Activity	1 (.06%)
Communication Disorders	1 (.06%)
Cranial Nerve Disorders	1 (.06%)
Depressed Mood Disorders	1 (.06%)
Gastrointestinal Conditions	1 (.06%)
Glaucoma And Ocular Hypertension	1 (.06%)
Headaches	1 (.06%)
Lipid Analyses	1 (.06%)
Lower Respiratory Tract Disorders	1 (.06%)
Mood Disorders	1 (.06%)
Myocardial	1 (.06%)
Neoplasm Related Morbidities	1 (.06%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Miglitol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Miglitol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.